HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Traditional But Trendy: Capsules And Tablets Lead VMS Delivery Formats Despite Gummy Growth

Executive Summary

Natural Marketing Institute survey found capsules (42%) and tablets (41%) are most popular supplement formats followed by gummies (35%). Results presented during a Council for Responsible Nutrition webinar showed younger consumers are willing to try formats such as tinctures, oral sprays and tablets.

You may also be interested in...



Gummy Format And Immunity Health Have Legs As Sales Drivers For US Supplement Market

“It's not that gummies have taken over the entire pill format,” says nutritional product business consultant Thomas Aarps. “But the trend is obviously to gummies.” Meanwhile, multiple COVID variants keep consumers attuned to immunity health. “Immunity is big, it's going to be big.”

Church & Dwight Wakes Up L'il Critters Children's Gummy Vitamin Line With Melatonin

Sold online and in stores at Target, L’il Critters Melatonin Gummies are $11.99 for 60, 1.5-mg melatonin gummies for use in children who have trouble falling asleep.

Gummy Vitamin Manufacturing Hurdles Grow With Demand For Novel Formulations

Gummy manufacturing challenges include stability of “decaying” active ingredients, loading all ingredients into limited space and inadequate testing, says Church & Dwight scientist Kristen Farr.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150819

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel